(R)-Methyl 4-(piperidin-2-yl)benzoate hydrochloride
97%
- Product Code: 37670
CAS:
1391574-76-7
| Molecular Weight: | 255.7405 g./mol | Molecular Formula: | C₁₃H₁₈ClNO₂ |
|---|---|---|---|
| EC Number: | MDL Number: | MFCD12910877 | |
| Melting Point: | Boiling Point: | ||
| Density: | Storage Condition: | room temperature |
Product Description:
This compound is primarily utilized in pharmaceutical research and development, particularly in the synthesis of active pharmaceutical ingredients (APIs). It serves as a key intermediate in the production of compounds targeting central nervous system disorders, such as neurodegenerative diseases and psychiatric conditions. Its structural features make it valuable for designing molecules with potential therapeutic effects, especially those interacting with specific receptors or enzymes in the brain. Additionally, it may be explored in medicinal chemistry for optimizing drug candidates with improved efficacy and selectivity. Its application extends to preclinical studies, where it aids in understanding biological pathways and evaluating pharmacological properties.
Sizes / Availability / Pricing:
| Size (g) | Availability | Price | Quantity |
|---|---|---|---|
| 0.100 | 10-20 days | £154.09 |
+
-
|
(R)-Methyl 4-(piperidin-2-yl)benzoate hydrochloride
This compound is primarily utilized in pharmaceutical research and development, particularly in the synthesis of active pharmaceutical ingredients (APIs). It serves as a key intermediate in the production of compounds targeting central nervous system disorders, such as neurodegenerative diseases and psychiatric conditions. Its structural features make it valuable for designing molecules with potential therapeutic effects, especially those interacting with specific receptors or enzymes in the brain. Additionally, it may be explored in medicinal chemistry for optimizing drug candidates with improved efficacy and selectivity. Its application extends to preclinical studies, where it aids in understanding biological pathways and evaluating pharmacological properties.
| Mechanism | - |
| Appearance | - |
| Longevity | - |
| Strength | - |
| Storage | - |
| Shelf Life | - |
| Allergen(s) | - |
| Dosage (Range) | - |
| Recommended Dosage | - |
| Dosage (Per Day) | - |
| Recommended Dosage (Per Day) | - |
| Mix Method | - |
| Heat Resistance | - |
| Stable in pH range | - |
| Solubility | - |
| Product Types | - |
| INCI | - |
Cart
No products
Subtotal:
£0.00
£0.00
Total :